Literature DB >> 15013124

Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function.

Richard W Troughton1, David L Prior, Jeremy J Pereira, Maureen Martin, Annette Fogarty, Annitta Morehead, Timothy G Yandle, A Mark Richards, Randall C Starling, James B Young, James D Thomas, Allan L Klein.   

Abstract

OBJECTIVES: This study was designed to characterize the importance of echocardiographic indexes, including newer indexes of diastolic function, as determinants of plasma B-type natriuretic peptide (BNP) levels in patients with systolic heart failure (SHF).
BACKGROUND: Plasma BNP levels have utility for diagnosing and managing heart failure. However, there is significant heterogeneity in BNP levels that is not explained by left ventricular size and function alone.
METHODS: In 106 patients with symptomatic SHF (left ventricular ejection fraction [LVEF] <0.35), we measured plasma BNP levels and performed comprehensive echocardiography with assessment of left ventricular diastolic function, including color M-mode (CMM) and tissue Doppler imaging (TDI), and of right ventricular (RV) function.
RESULTS: Median plasma BNP levels were elevated and increased with greater severity of diastolic dysfunction. We found significant correlations (p < 0.001 for all) between BNP and indexes of myocardial relaxation (early diastolic velocity: r = -0.26), compliance (deceleration time: r = -0.55), and filling pressure (early transmitral to early annular diastolic velocity ratio: r = 0.51; early transmitral flow to the velocity of early left ventricular flow propagation ratio: r = 0.41). In multivariate analysis, overall diastolic stage, LVEF, RV systolic dysfunction, mitral regurgitation (MR) severity, age and creatinine clearance were independent predictors of BNP levels (model fit r = 0.8, p < 0.001).
CONCLUSIONS: Plasma BNP levels are significantly related to newer diastolic indexes measured from TDI and CMM in SHF. Heterogeneity of BNP levels in patients with SHF reflects the severity of diastolic abnormality, RV dysfunction, and MR in addition to LVEF, age, and renal function. These findings may explain the powerful relationship of BNP to symptoms and prognosis in SHF.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15013124     DOI: 10.1016/j.jacc.2003.08.046

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  45 in total

1.  The cause of B-type natriuretic peptide elevation and the dose-dependent effect of angiotensin-converting enzyme inhibitor on patients late after tetralogy of Fallot repair.

Authors:  Takuo Furukawa; Tomoaki Murakami; Michihiko Ueno; Atsuhito Takeda; Satoshi Yakuwa; Hirokuni Yamazawa
Journal:  Pediatr Cardiol       Date:  2011-09-30       Impact factor: 1.655

Review 2.  Neurohormonal modulation in heart failure of ischemic etiology: correlates with left ventricular remodeling.

Authors:  Roberto Latini; Serge Masson; Lidia Staszewsky; Simona Barlera
Journal:  Curr Heart Fail Rep       Date:  2006-12

3.  Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study.

Authors:  Frans H Rutten; Karel G M Moons; Maarten-Jan M Cramer; Diederick E Grobbee; Nicolaas P A Zuithoff; Jan-Willem J Lammers; Arno W Hoes
Journal:  BMJ       Date:  2005-12-01

4.  Diminished global arginine bioavailability as a metabolic defect in chronic systolic heart failure.

Authors:  W H Wilson Tang; Kevin Shrestha; Zeneng Wang; Richard W Troughton; Allan L Klein; Stanley L Hazen
Journal:  J Card Fail       Date:  2013-02       Impact factor: 5.712

5.  Nitric oxide bioavailability and adiponectin production in chronic systolic heart failure: relation to severity of cardiac dysfunction.

Authors:  W H Wilson Tang; Kevin Shrestha; Wilson Tong; Zeneng Wang; Richard W Troughton; Allen G Borowski; Allan L Klein; Stanley L Hazen
Journal:  Transl Res       Date:  2013-03-13       Impact factor: 7.012

6.  Prognostic value of brain natriuretic peptide and enhanced ventilatory response to exercise in patients with chronic heart failure.

Authors:  Angela Beatrice Scardovi; Renata De Maria; Andrea Celestini; Claudio Coletta; Nadia Aspromonte; Silvia Perna; Marina Parolini; Roberto Ricci
Journal:  Intern Emerg Med       Date:  2008-06-17       Impact factor: 3.397

Review 7.  Genetic variation in the natriuretic peptide system and heart failure.

Authors:  David E Lanfear
Journal:  Heart Fail Rev       Date:  2008-10-11       Impact factor: 4.214

8.  Treatment of sleep apnea in congestive heart failure with a dental device: the effect on brain natriuretic peptide and quality of life.

Authors:  Mahmoud Eskafi; Charles Cline; Maria Nilner; Bo Israelsson
Journal:  Sleep Breath       Date:  2006-06       Impact factor: 2.816

Review 9.  Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure.

Authors:  A Palazzuoli; M Gallotta; I Quatrini; R Nuti
Journal:  Vasc Health Risk Manag       Date:  2010-06-01

10.  Relationship between B-type natriuretic peptide levels and echocardiographic indices of left ventricular filling pressures in post-cardiac surgery patients.

Authors:  Alessandro Salustri; Elena Cerquetani; Mara Piccoli; Guglielmo Pastena; Alfredo Posteraro; Elisabetta Amici; Salvatore La Carrubba; Sherif Bakir; Wael Abdulrahman Al Mahmeed
Journal:  Cardiovasc Ultrasound       Date:  2009-10-28       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.